Effect of HAART on liver-related mortality in patients with HIV/HCV coinfection.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 14975627)

Published in Lancet on February 14, 2004

Authors

Julia del Amo, Ildefonso Hernández-Aguado, Santiago Pérez-Hoyos

Articles citing this

HIV/HCV coinfection, HAART, and liver-related mortality. Lancet (2004) 0.75

Articles by these authors

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS (2010) 5.85

When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. Ann Intern Med (2011) 5.35

Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med (2012) 3.44

It is time to abandon "expected bladder capacity." Systematic review and new models for children's normal maximum voided volumes. Neurourol Urodyn (2013) 2.04

[The Cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank; organizational issues, main findings and losses to follow-up]. Enferm Infecc Microbiol Clin (2011) 1.92

[Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results]. Enferm Infecc Microbiol Clin (2007) 1.83

Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. Diabetes (2002) 1.81

Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol (2002) 1.79

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study. Lancet Infect Dis (2011) 1.68

The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS (2011) 1.65

Methodology in diagnostic laboratory test research in clinical chemistry and clinical chemistry and laboratory medicine. Clin Chem (2004) 1.65

The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users. Addiction (2008) 1.58

[HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)]. Enferm Infecc Microbiol Clin (2009) 1.57

Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category. AIDS (2003) 1.55

Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms. AIDS (2012) 1.55

Maternal and foetal angiogenic imbalance in congenital heart defects. Eur Heart J (2013) 1.50

Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia. Clin Infect Dis (2011) 1.50

Trends in AIDS and mortality in HIV-infected subjects with hemophilia from 1985 to 2003: the competing risks for death between AIDS and liver disease. J Acquir Immune Defic Syndr (2006) 1.50

The impact of including different study designs in meta-analyses of diagnostic accuracy studies. Eur J Epidemiol (2012) 1.42

[Patient characteristics and health care burden during the influenza A (H1N1) 2009 pandemic in the university Hospital Vall d'Hebron of Barcelona]. Enferm Infecc Microbiol Clin (2011) 1.38

Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women. Am J Epidemiol (2008) 1.35

Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality. Curr HIV Res (2009) 1.30

A combined analysis of the short-term effects of photochemical air pollutants on mortality within the EMECAM project. Environ Health Perspect (2002) 1.26

Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain. AIDS Res Hum Retroviruses (2006) 1.26

Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. Clin Infect Dis (2012) 1.25

The contribution of a gender perspective to the understanding of migrants' health. J Epidemiol Community Health (2007) 1.20

Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy. Curr HIV Res (2008) 1.17

Relation between temperature and mortality in thirteen Spanish cities. Int J Environ Res Public Health (2010) 1.13

Impact of hepatitis C infection on long-term mortality of injecting drug users from 1990 to 2002: differences before and after HAART. AIDS (2006) 1.12

Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. Arch Intern Med (2010) 1.12

The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study. AIDS (2012) 1.11

Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART. AIDS (2007) 1.08

HIV Infection in Migrant Populations in the European Union and European Economic Area in 2007-2012: An Epidemic on the Move. J Acquir Immune Defic Syndr (2015) 1.05

Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: effectiveness goes on. AIDS (2006) 0.99

Reducing sexual risk behavior among steady heterosexual serodiscordant couples in a testing and counseling program. Sex Transm Dis (2009) 0.97

Risk of tuberculosis following HIV seroconversion in high-income countries. Thorax (2012) 0.96

Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001. J Epidemiol Community Health (2004) 0.96

Risk, predictors, and mortality associated with non-AIDS events in newly diagnosed HIV-infected patients: role of antiretroviral therapy. AIDS (2013) 0.96

HIV infection among people of foreign origin voluntarily tested in Spain. A comparison with national subjects. Sex Transm Infect (2002) 0.92

Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care. Antivir Ther (2012) 0.91

Impact of tuberculosis on HIV disease progression in persons with well-documented time of HIV seroconversion. J Acquir Immune Defic Syndr (2003) 0.90

Overinterpretation of clinical applicability in molecular diagnostic research. Clin Chem (2009) 0.90

[Effect of psychosocial work environment and job satisfaction on burnout syndrome among specialist physicians]. Gac Sanit (2008) 0.89

Unhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis C. PLoS One (2012) 0.88

"Omics" research, monetization of intellectual property and fragmentation of knowledge: can clinical epidemiology strengthen integrative research? J Clin Epidemiol (2007) 0.87

Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord. AIDS (2014) 0.87

Educational level and HIV disease progression before and after the introduction of HAART: a cohort study in 989 HIV seroconverters in Spain. Sex Transm Infect (2011) 0.87

Unexpected findings at imaging: predicting frequency in various types of studies. Eur J Radiol (2009) 0.85

Air pollution and hospital emergency room admissions for chronic obstructive pulmonary disease in Valencia, Spain. Arch Environ Health (2002) 0.85

HIV health experiences among migrant Africans in Europe: how are we doing? AIDS (2003) 0.84

Ultrasensitive real-time PCR for the clinical management of visceral leishmaniasis in HIV-Infected patients. Am J Trop Med Hyg (2013) 0.84

Anal human papillomavirus genotype distribution in HIV-infected men who have sex with men by geographical origin, age, and cytological status in a Spanish cohort. J Clin Microbiol (2013) 0.83

Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis. AIDS (2013) 0.83

Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries. Clin Infect Dis (2015) 0.83

Definition of advanced age in HIV infection: looking for an age cut-off. AIDS Res Hum Retroviruses (2012) 0.82

Persistence of novel first-line antiretroviral regimes in a cohort of HIV-positive subjects, CoRIS 2008-2010. Antivir Ther (2012) 0.81

Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients. Eur J Epidemiol (2011) 0.81

Health information and advocacy for "Health in All Policies": a research agenda. J Epidemiol Community Health (2010) 0.81

QUADOMICS: an adaptation of the Quality Assessment of Diagnostic Accuracy Assessment (QUADAS) for the evaluation of the methodological quality of studies on the diagnostic accuracy of '-omics'-based technologies. Clin Biochem (2008) 0.81

Methodological deficits in diagnostic research using '-omics' technologies: evaluation of the QUADOMICS tool and quality of recently published studies. PLoS One (2010) 0.81

Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension. Hypertension (2005) 0.81

Postovulatory aging of oocytes decreases reproductive fitness and longevity of offspring. Biol Reprod (2002) 0.80

Imputation of the Date of HIV Seroconversion in a Cohort of Seroprevalent Subjects: Implications for Analysis of Late HIV Diagnosis. AIDS Res Treat (2011) 0.80

Effectiveness of the WC/rBS oral cholera vaccine in the prevention of traveler's diarrhea: a prospective cohort study. Hum Vaccin Immunother (2013) 0.79

[Observacional study: evaluation of the diagnostic research methodology in Spain after STARD publication]. Med Clin (Barc) (2009) 0.79

[Determination of the beginning of follow-up in longitudinal studies applied to HIV infections]. Rev Esp Salud Publica (2004) 0.78

Prevalence of undiagnosed HIV infection in the general population having blood tests within primary care in Madrid, Spain. Sex Transm Infect (2012) 0.78

Violence in adulthood and mental health: gender and immigrant status. J Interpers Violence (2013) 0.78

Sex-specific, independent associations of insulin resistance with erythrocyte sedimentation rate in apparently healthy subjects. Thromb Haemost (2007) 0.78

Increased syphilis trend among patients in an AIDS information and prevention center. Gac Sanit (2011) 0.78

[Health services utilization according to gender in a cohort of intravenous drug users infected with HIV]. Med Clin (Barc) (2003) 0.77

How useful is it clinically to analyse the K-ras mutational status for the diagnosis of exocrine pancreatic cancer? A systematic review and meta-analysis. Eur J Clin Invest (2011) 0.77

Changes in lung-cancer mortality trends in Spain. Int J Cancer (2002) 0.77

[Short-term relationship between air pollution and mortality in 13 Spanish cities]. Med Clin (Barc) (2003) 0.77

State downsizing as a determinant of infant mortality and achievement of Millennium Development Goal 4. Int J Health Serv (2009) 0.76

Role of the dental surgeon in the early detection of adults with underlying HIV infection/AIDS. Med Oral Patol Oral Cir Bucal (2012) 0.76

[Preventive intervention in venues for interaction used by men who have sex with men]. Gac Sanit (2009) 0.76

[Effect of distinct sociodemographic variables on progression of HIV infection in a cohort of drug users]. Gac Sanit (2008) 0.76

[Editor's note on the editorial process and the interaction between authors and editors]. Gac Sanit (2003) 0.75

Assessing the social meaning, value and implications of research in genomics. J Epidemiol Community Health (2007) 0.75

[Cardiovascular risk in human immunodeficiency virus-infected patients in Spain. Author's reply]. Enferm Infecc Microbiol Clin (2013) 0.75

Sharing hypotheses and ideas in public health research: contributing to the research agenda. J Epidemiol Community Health (2007) 0.75

[Effect of highly active antiretroviral treatment in HIV infection: role of epidemiological studies]. Med Clin (Barc) (2006) 0.75

Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals. Medicine (Baltimore) (2016) 0.75

[The Public Health Services Port-folio in the National Health System: the contribution of the Central Government of Spain]. Rev Esp Salud Publica (2010) 0.75

[Successes and failures in the management of public health crisis in Spain]. Gac Sanit (2009) 0.75

[Head masters' perception of school-based hostility in Alicante, Spain: a qualitative study]. Rev Esp Salud Publica (2006) 0.75